Roper Technologies Appoints Amy Woods Brinkley as Chair of the Board of Directors
March 22, 2021
SARASOTA, Fla. -- Roper Technologies, Inc. (NYSE: ROP) announced that Amy Woods Brinkley has been appointed Chair of the Company’s Board of Directors, effective June 1, 2021. Ms. Brinkley succeeds Wilbur J. Prezzano, who is retiring from Roper’s Board in June, consistent with the Company’s mandatory retirement guidelines. Ms. Brinkley has served as a Director of [...]
Thermo Fisher Scientific Announces New Human Plasma-Like Cell Culture Medium
March 22, 2021
First-of-its-kind medium resembles the natural cellular environment found in the human body for more physiologically relevant cell culture models CARLSBAD, Calif. -- Thermo Fisher Scientific today launched the new Gibco Human Plasma-like Medium (HPLM), the first cell culture medium on the market that mimics the metabolic profile of human plasma that is designed to provide researchers [...]
Establishing an automated system for the analysis of SARS-CoV-2 in wastewater
March 19, 2021
HOKKAIDO UNIVERSITY -- On March 19, 2021, Hokkaido University, Robotic Biology Institute Inc., iLAC Co., Ltd., and Shionogi & Co., Ltd. have entered into a memorandum of understanding (MOU) toward the establishment of an automated system for the analysis of the novel coronavirus (SARS-CoV-2) in wastewater. The joint project aims to establish an automated analytical [...]
Bioanalytical Systems, Inc. Announces Corporate Name Change to Inotiv, Inc.
March 19, 2021
WEST LAFAYETTE, Ind. -- Bioanalytical Systems, Inc. (NASDAQ:BASI) (the “Company”, “We”, “Our” or “Inotiv”), a leading provider of nonclinical and analytical contract research services, today announced a change of the Company’s corporate name from Bioanalytical Systems, Inc. to Inotiv, Inc. The name change was approved by the Company’s shareholders on March 18, 2021, at the [...]
Euformatics and Síntese Biotecnologia partner for first sales channel agreement in South America
March 18, 2021
HELSINKI, Finland -- Euformatics, a world-leader in NGS data quality control applications and variant interpretation solutions, has signed a joint market engagement agreement with Síntese Biotecnologia (Síntese) to spearhead its expansion into the South American NGS market. The move comes as part of Euformatics’ renewed strategy to grow its business globally in new markets, with [...]
Illumina Announces Board Changes
March 18, 2021
Jay Flatley to step down from the Board; John W. Thompson to be appointed new Chair SAN DIEGO -- Illumina, Inc. (NASDAQ: ILMN) (the “Company”) today announced that Jay Flatley has decided to step down from the Board of Directors and John W. Thompson will be appointed as the Company’s new Chair of the Board. These [...]
FLIR Systems Wins $8.0M R&D Contract for Next-Generation Chemical Detection Technology
March 18, 2021
FLIR to Team with Purdue University to Develop Novel Ion Separation and Analysis Technologies with Funding from the Defense Threat Reduction Agency ARLINGTON, Va. ― FLIR Systems, Inc. (NASDAQ: FLIR) announced it has won a contract worth up to $8.0 million from the United States Defense Threat Reduction Agency’s Joint Science and Technology Office (DTRA JSTO) [...]
Euformatics and Síntese Biotecnologia partner for first sales channel agreement in South America
March 18, 2021
HELSINKI, Finland, – Euformatics, a world-leader in NGS data quality control applications and variant interpretation solutions, has signed a joint market engagement agreement with Síntese Biotecnologia (Síntese) to spearhead its expansion into the South American NGS market. The move comes as part of Euformatics’ renewed strategy to grow its business globally in new markets, with [...]
March 18, 2021
New End-to-End Compliant-Ready Workflow Helps Biotherapeutic Protein Manufacturers Meet Regulatory and Attribute-Based Product Analysis Requirements for Drug Identity, Purity, and Quality NEWS SUMMARY: New Peptide MAM (multi-attribute method) workflow for the BioAccord LC-MS System monitors product quality attributes that can affect efficacy and safety of innovator drugs and biosimilars. End-to-end streamlined LC-MS workflow for analyzing [...]
March 18, 2021
Acuity Technology Enables the Possibility to See the 3D Genome in situ and at Single-Cell and Sub-Cellular Resolution SAN JOSE, Calif. & BOSTON -- Acuity Spatial Genomics, Inc. today announced the completion of a majority investment by Bruker Corporation (Nasdaq: BRKR). Acuity is a new venture focused on opening a new frontier in spatial 3D genomics and [...]
